| Dr Sakina B Naqvi, MD | |
|
3100 Kennard St Ste 220, Maplewood, MN 55109-5465 | |
| (651) 471-1166 | |
| (651) 232-4972 |
| Full Name | Dr Sakina B Naqvi |
|---|---|
| Gender | Female |
| Speciality | Pulmonary Disease |
| Experience | 22 Years |
| Location | 3100 Kennard St Ste 220, Maplewood, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619108693 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 53422 (Minnesota) | Primary |
| 207RC0200X | Internal Medicine - Critical Care Medicine | 53422 (Minnesota) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Healtheast St John's Hospital | Maplewood, MN | Hospital |
| Healtheast Woodwinds Hospital | Woodbury, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Healtheast Medical Research Institute | 3971407636 | 500 |
News Archive
An interview with Dr. Carmen Escuriola-Ettingshausen MD, Mörfelden-Walldorf, Germany on providing personalized care for bleeding disorders.
Cubist Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted the Company's late-stage antibiotic candidate ceftolozane/tazobactam (CXA-201) Fast Track status in the previously granted Qualified Infectious Disease Product indications, Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia and Complicated Urinary Tract Infections.
Healthcare Management Systems, Inc. ® announced today the launch of a new interoperability product for customers that will enable the exchange of clinical data between third party systems, health information exchanges, and public registries. The new product will assist clients in qualifying for the American Recovery and Reinvestment Act HITECH stimulus funds.
In a study that included more than 2,700 women receiving care in primary care clinics, those who were screened for partner violence and received a partner violence resource list did not experience significant differences for several outcomes, including overall quality of life, general health, and recurrence of partner violence, compared to women who just received a partner violence resource list, according to a study in the August 15 issue of JAMA, a theme issue on violence and human rights.
In the South East of England, a patient experience study of 18 early stage breast cancer patients who opted for single dose intraoperative radiotherapy, found positive patient reported outcomes for this alternative to standard daily external beam radiotherapy.
› Verified 6 days ago
| Entity Name | Healtheast Woodwinds Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356309322 PECOS PAC ID: 9638082563 Enrollment ID: O20031107000110 |
News Archive
An interview with Dr. Carmen Escuriola-Ettingshausen MD, Mörfelden-Walldorf, Germany on providing personalized care for bleeding disorders.
Cubist Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted the Company's late-stage antibiotic candidate ceftolozane/tazobactam (CXA-201) Fast Track status in the previously granted Qualified Infectious Disease Product indications, Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia and Complicated Urinary Tract Infections.
Healthcare Management Systems, Inc. ® announced today the launch of a new interoperability product for customers that will enable the exchange of clinical data between third party systems, health information exchanges, and public registries. The new product will assist clients in qualifying for the American Recovery and Reinvestment Act HITECH stimulus funds.
In a study that included more than 2,700 women receiving care in primary care clinics, those who were screened for partner violence and received a partner violence resource list did not experience significant differences for several outcomes, including overall quality of life, general health, and recurrence of partner violence, compared to women who just received a partner violence resource list, according to a study in the August 15 issue of JAMA, a theme issue on violence and human rights.
In the South East of England, a patient experience study of 18 early stage breast cancer patients who opted for single dose intraoperative radiotherapy, found positive patient reported outcomes for this alternative to standard daily external beam radiotherapy.
› Verified 6 days ago
| Entity Name | Healtheast Medical Research Institute |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639125503 PECOS PAC ID: 3971407636 Enrollment ID: O20031124000507 |
News Archive
An interview with Dr. Carmen Escuriola-Ettingshausen MD, Mörfelden-Walldorf, Germany on providing personalized care for bleeding disorders.
Cubist Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted the Company's late-stage antibiotic candidate ceftolozane/tazobactam (CXA-201) Fast Track status in the previously granted Qualified Infectious Disease Product indications, Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia and Complicated Urinary Tract Infections.
Healthcare Management Systems, Inc. ® announced today the launch of a new interoperability product for customers that will enable the exchange of clinical data between third party systems, health information exchanges, and public registries. The new product will assist clients in qualifying for the American Recovery and Reinvestment Act HITECH stimulus funds.
In a study that included more than 2,700 women receiving care in primary care clinics, those who were screened for partner violence and received a partner violence resource list did not experience significant differences for several outcomes, including overall quality of life, general health, and recurrence of partner violence, compared to women who just received a partner violence resource list, according to a study in the August 15 issue of JAMA, a theme issue on violence and human rights.
In the South East of England, a patient experience study of 18 early stage breast cancer patients who opted for single dose intraoperative radiotherapy, found positive patient reported outcomes for this alternative to standard daily external beam radiotherapy.
› Verified 6 days ago
| Entity Name | Healtheast St Joseph's Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134186273 PECOS PAC ID: 2365348869 Enrollment ID: O20031208000245 |
News Archive
An interview with Dr. Carmen Escuriola-Ettingshausen MD, Mörfelden-Walldorf, Germany on providing personalized care for bleeding disorders.
Cubist Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted the Company's late-stage antibiotic candidate ceftolozane/tazobactam (CXA-201) Fast Track status in the previously granted Qualified Infectious Disease Product indications, Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia and Complicated Urinary Tract Infections.
Healthcare Management Systems, Inc. ® announced today the launch of a new interoperability product for customers that will enable the exchange of clinical data between third party systems, health information exchanges, and public registries. The new product will assist clients in qualifying for the American Recovery and Reinvestment Act HITECH stimulus funds.
In a study that included more than 2,700 women receiving care in primary care clinics, those who were screened for partner violence and received a partner violence resource list did not experience significant differences for several outcomes, including overall quality of life, general health, and recurrence of partner violence, compared to women who just received a partner violence resource list, according to a study in the August 15 issue of JAMA, a theme issue on violence and human rights.
In the South East of England, a patient experience study of 18 early stage breast cancer patients who opted for single dose intraoperative radiotherapy, found positive patient reported outcomes for this alternative to standard daily external beam radiotherapy.
› Verified 6 days ago
| Entity Name | Healtheast St John's Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447218482 PECOS PAC ID: 9234035742 Enrollment ID: O20031208000320 |
News Archive
An interview with Dr. Carmen Escuriola-Ettingshausen MD, Mörfelden-Walldorf, Germany on providing personalized care for bleeding disorders.
Cubist Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted the Company's late-stage antibiotic candidate ceftolozane/tazobactam (CXA-201) Fast Track status in the previously granted Qualified Infectious Disease Product indications, Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia and Complicated Urinary Tract Infections.
Healthcare Management Systems, Inc. ® announced today the launch of a new interoperability product for customers that will enable the exchange of clinical data between third party systems, health information exchanges, and public registries. The new product will assist clients in qualifying for the American Recovery and Reinvestment Act HITECH stimulus funds.
In a study that included more than 2,700 women receiving care in primary care clinics, those who were screened for partner violence and received a partner violence resource list did not experience significant differences for several outcomes, including overall quality of life, general health, and recurrence of partner violence, compared to women who just received a partner violence resource list, according to a study in the August 15 issue of JAMA, a theme issue on violence and human rights.
In the South East of England, a patient experience study of 18 early stage breast cancer patients who opted for single dose intraoperative radiotherapy, found positive patient reported outcomes for this alternative to standard daily external beam radiotherapy.
› Verified 6 days ago
| Entity Name | Healtheast Care System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194787465 PECOS PAC ID: 7214833763 Enrollment ID: O20031208000483 |
News Archive
An interview with Dr. Carmen Escuriola-Ettingshausen MD, Mörfelden-Walldorf, Germany on providing personalized care for bleeding disorders.
Cubist Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted the Company's late-stage antibiotic candidate ceftolozane/tazobactam (CXA-201) Fast Track status in the previously granted Qualified Infectious Disease Product indications, Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia and Complicated Urinary Tract Infections.
Healthcare Management Systems, Inc. ® announced today the launch of a new interoperability product for customers that will enable the exchange of clinical data between third party systems, health information exchanges, and public registries. The new product will assist clients in qualifying for the American Recovery and Reinvestment Act HITECH stimulus funds.
In a study that included more than 2,700 women receiving care in primary care clinics, those who were screened for partner violence and received a partner violence resource list did not experience significant differences for several outcomes, including overall quality of life, general health, and recurrence of partner violence, compared to women who just received a partner violence resource list, according to a study in the August 15 issue of JAMA, a theme issue on violence and human rights.
In the South East of England, a patient experience study of 18 early stage breast cancer patients who opted for single dose intraoperative radiotherapy, found positive patient reported outcomes for this alternative to standard daily external beam radiotherapy.
› Verified 6 days ago
| Entity Name | Fairview Express Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053952606 PECOS PAC ID: 3375645179 Enrollment ID: O20081028000548 |
News Archive
An interview with Dr. Carmen Escuriola-Ettingshausen MD, Mörfelden-Walldorf, Germany on providing personalized care for bleeding disorders.
Cubist Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted the Company's late-stage antibiotic candidate ceftolozane/tazobactam (CXA-201) Fast Track status in the previously granted Qualified Infectious Disease Product indications, Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia and Complicated Urinary Tract Infections.
Healthcare Management Systems, Inc. ® announced today the launch of a new interoperability product for customers that will enable the exchange of clinical data between third party systems, health information exchanges, and public registries. The new product will assist clients in qualifying for the American Recovery and Reinvestment Act HITECH stimulus funds.
In a study that included more than 2,700 women receiving care in primary care clinics, those who were screened for partner violence and received a partner violence resource list did not experience significant differences for several outcomes, including overall quality of life, general health, and recurrence of partner violence, compared to women who just received a partner violence resource list, according to a study in the August 15 issue of JAMA, a theme issue on violence and human rights.
In the South East of England, a patient experience study of 18 early stage breast cancer patients who opted for single dose intraoperative radiotherapy, found positive patient reported outcomes for this alternative to standard daily external beam radiotherapy.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sakina B Naqvi, MD 3100 Kennard St Ste 220, Maplewood, MN 55109-5465 Ph: (651) 471-1166 | Dr Sakina B Naqvi, MD 3100 Kennard St Ste 220, Maplewood, MN 55109-5465 Ph: (651) 471-1166 |
News Archive
An interview with Dr. Carmen Escuriola-Ettingshausen MD, Mörfelden-Walldorf, Germany on providing personalized care for bleeding disorders.
Cubist Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted the Company's late-stage antibiotic candidate ceftolozane/tazobactam (CXA-201) Fast Track status in the previously granted Qualified Infectious Disease Product indications, Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia and Complicated Urinary Tract Infections.
Healthcare Management Systems, Inc. ® announced today the launch of a new interoperability product for customers that will enable the exchange of clinical data between third party systems, health information exchanges, and public registries. The new product will assist clients in qualifying for the American Recovery and Reinvestment Act HITECH stimulus funds.
In a study that included more than 2,700 women receiving care in primary care clinics, those who were screened for partner violence and received a partner violence resource list did not experience significant differences for several outcomes, including overall quality of life, general health, and recurrence of partner violence, compared to women who just received a partner violence resource list, according to a study in the August 15 issue of JAMA, a theme issue on violence and human rights.
In the South East of England, a patient experience study of 18 early stage breast cancer patients who opted for single dose intraoperative radiotherapy, found positive patient reported outcomes for this alternative to standard daily external beam radiotherapy.
› Verified 6 days ago
Andrzej Petryk, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1580 Beam Ave, Maplewood, MN 55109 Phone: 651-779-7978 Fax: 651-779-7656 | |
Dr. Rahul Koranne, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1575 Beam Ave, Maplewood, MN 55109 Phone: 651-232-7800 | |
Sherry A Moriarty, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1850 Beam Ave, Maplewood, MN 55109 Phone: 651-779-2500 Fax: 651-770-8834 | |
Endea J Curry, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2165 White Bear Ave N, Maplewood, MN 55109 Phone: 651-523-9800 Fax: 651-523-9801 | |
Ovidiu George Ardeleanu, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 2165 White Bear Ave N, Maplewood, MN 55109 Phone: 651-523-9800 Fax: 651-523-9801 | |
Madison Therese Brickner, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 2945 Hazelwood St Ste 100, Maplewood, MN 55109 Phone: 651-232-7800 | |
Dr. Thomas Martin Hauth, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2945 Hazelwood St, Maplewood, MN 55109 Phone: 651-232-7800 |